Eon Labs famotidine
This article was originally published in The Tan Sheet
Executive Summary
Firm's application (ANDA 76-101) for generic equivalent to J&J/Merck's Pepcid AC approved by FDA Oct. 21. Eon likely will partner with another company to bring the H2 antagonist to market but has no imminent launch plans. Five other companies hold ANDA approval for 10 mg tablets (1"The Tan Sheet" April 8, 2002, In Brief)...
You may also be interested in...
Torpharm ANDA
Private labeler's famotidine 10 mg tablets (J&J/Merck's Pepcid AC) approved by FDA March 12. ANDA (75-610) marks fifth private label approval for the H2 antagonist, behind Ivax, Teva (licensed by Perrigo), Dr. Reddy's Labs (licensed by Leiner), Genpharm (1"The Tan Sheet" Jan. 7, 2002, In Brief)...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.